SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 13, 2026

ALDX

Aldeyra Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4d ago
Insider cluster: 2 insiders, $135K total
Actionable Insight • Neutral

The director's purchase is the larger signal, but at 0.35% of market cap it is modest. Monitor for any upcoming corporate catalyst (e.g., trial data, partnership, or financing) that may have prompted the buying, as the stock is micro-cap with high volatility.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$0.6696
T+0 close · Nov 13, 2026 · via day close
Latest settled
+3.63%
T+1 · $0.6939
Vs SPY
+4.64%
α at T+1
Next horizon
T+5
in 6d
  1. T+0 · Nov 16 $0.6696entry
  2. T+1 · 10h ago +3.63%α +4.64% · $0.6939
  3. T+5 · in 6d Pending
  4. T+20 · in 28d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Aldeyra insiders, including a director and the CFO, made open-market purchases totaling $135K on November 11, 2026. The director's $129K purchase represents 0.33% of the company's $39M market cap, a modest but notable insider vote of confidence.

Key Financial Metrics

Direction
buying
Total Value
$135.4K
Insiders
2

Key Facts

  • Director Richard purchased 200,000 shares for $129K at $0.64/share on 2026-11-11
  • CFO Alfieri purchased 10,000 shares for $7K at $0.65/share on 2026-11-11
  • Total open-market purchases of $135K represent 0.35% of $39M market cap
  • Both purchases were not under a 10b5-1 plan
  • No insider sales were reported in the cluster window

Financial Impact

Total insider purchases of $135K, or 0.35% of market cap

insider ownership

Risk Factors

  • Micro-cap stock with $39M market cap is inherently volatile and illiquid
  • Insider purchases at this scale are not a guarantee of near-term positive news
  • No disclosed catalyst or material event in the filing window

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ALDX-1794605618962

Track record

12 reports on ALDX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +59.67% at T+60 after the Aug 16, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 17, 2026today 8-K Bearish 7/10 Entry $0.6799 Now $0.6939 −2.06% settles Dec 17
  2. Nov 13, 20264d ago Insider Cluster Neutral 4/10 Viewing Entry $0.6696 Now $0.6939 +3.63% settles Dec 15
  3. Nov 12, 20265d ago SC 13G/A Bearish 5/10 Entry $0.6301 Now $0.6939 −10.13% settles Dec 11
  4. Nov 9, 20268d ago 8-K Bearish 6/10 Entry $0.6291 Now $0.6939 −10.30% settles Dec 9
  5. Nov 6, 202611d ago SC 13G Neutral 3/10 Entry $0.6337 Now $0.6939 +9.50% settles Dec 7
  6. Nov 4, 202613d ago Institutional Cluster Bearish 4/10 Entry $0.6474 Now $0.6939 −7.18% settles Dec 3
  7. Sep 29, 20267w ago 8-K Bullish 7/10 Entry $1.32 to $0.6412 Now $0.6939 −47.43% ▼ −51.42% −52.14% vs SPY
  8. Aug 16, 202613w ago Institutional Cluster Bearish 6/10 Entry $1.56 to $1.37 Now $0.6939 +55.52% ▲ +12.18% +10.20% vs SPY
  9. Jul 30, 202615w ago 8-K Neutral 2/10 Entry $1.54 to $1.49 Now $0.6939 −54.94% ▼ −3.57% −6.56% vs SPY
  10. Apr 27, 202629w ago DEFA14A Neutral 2/10 Entry $1.57 to $1.78 Now $0.6939 −55.80% ▲ +13.38% +7.91% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026